NUVB (Nuvation Bio Inc.) Net earnings per share growth this year

NUVB (Nuvation Corp) - company brandmark

Nuvation Bio Inc. (NUVB) strives to solidify its status as an authoritative developer of innovative small molecules for the therapy of complex tumors. Tracking annual EPS growth demonstrates progress toward this goal, where the value 32.40 denotes the current figure. However, geopolitical tensions are severing research ties despite colossal market demand for treatments for advanced solid neoplasms.

Earnings per share growth in current year: Nuvation Bio Inc (NUVB) for 07/04/2022 - 11/16/2026

Financial and market metric breakdowns for nuvationbio.com (NUVB)

- business market valuation indicators:
Summary company analysis:NUVB Nuvation Bio Inc.
Signature product of Nuvation Bio Inc.

For the oncology biotech Nuvation Bio Inc. (NUVB), which operates under high cash burn conditions, the current year-over-year EPS trend on GURU.Markets reflects the efficiency of its capital management. This indicator measures the percentage change in net income per share, allowing for an assessment of the company's solvency trends and financial leverage risks during a period of unstable revenue.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year dayonebio.com (DAWN)|Earnings per share growth in current year Monopar Corp (MNPR)|INBX - Earnings per share growth rate in current year|Earnings per share growth in current year I-Mab Inc. IMAB|Fennec - Earnings per share growth in current year|HRTX - Earnings per share growth in current year|Earnings per share growth rate in current year Nuvectis Pharma, Inc.|CHRS: Earnings growth in current year|Net earnings per share change in current year Corbus Pharma CRBP|Net earnings per share growth this year CRDF|Earnings per share growth rate in current year BeyondSpring Inc. BYSI|Net earnings per share growth this year BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Earnings per share increase in current year|Citius Pharmaceuticals, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Earnings growth in current year|Earnings per share increase in current year CANF (Can-Fite BioPharma, Ltd.)|APRE: Earnings growth in current year|Earnings per share growth rate in current year Kazia (KZIA)|Earnings per share growth in current year silexion.com|NCNA: Earnings per share increase in current year|Earnings growth in current year CMRX|Earnings growth in current year Cyclacel, Inc. (CYCC)|Earnings per share growth in current year G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year